New Advanced Electroporation System for Vaccine Development
Product News Apr 16, 2012
The New AgilePulse® In Vivo Electroporation System possesses unique, variable pulse amplitude technology for vaccine delivery or gene therapy applications.
Patented Pulse Agile™ waveforms consist of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues.
Gene expression in skin is 100-fold higher when delivery is enhanced by electroporation compared to injection alone.
• Patented Pulse Agile® technology
• Resistance measurement for proper needle placement and reproducibility
• Specially designed needle arrays for intra-muscular or intra-dermal applications
• Enhanced immune response
• Increased Ag-specific T-cell response
• Gene expression is 100-fold higher